AJR F and L Medical Products: Radiation Protection & More
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Right arrow Help viewing high resolution images
Right arrow Return to article
Hotlight (NEW!)
Right arrow
What's Hotlight?

The following table or figure may be downloaded to PowerPoint for personal use in teaching and presentations. This feature is available to all subscribers to the journal.

You MUST read and follow the guidelines at Request to Reproduce AJR Content if you are distributing or using AJR content beyond academic use (limited distribution, non-revenue producing, or educational purposes).

(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)



Fig. 3C. 67-year-old man with clear cell carcinoma (arrow) of the kidney. Unenhanced (A), vascular phase (B), and nephrographic phase (C) CT scans. Measurements of Hounsfield density show avid enhancement on both vascular and nephrographic phase scans. Enhancement is 131 H on vascular phase and 123 H on nephrographic phase. Tumor-to-aorta enhancement ratio and tumor-to-kidney enhancement ratio are 0.66 and 0.54, respectively. These values have negative predictive value for papillary renal cell carcinoma of 98%, essentially excluding possibility of papillary cell type carcinoma.





Right arrow Return to article
Hotlight (NEW!)
Right arrow
What's Hotlight?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS